NR4A2 and early-onset autosomal dominant Alzheimer disease: Even in absence of genetic variants in the NR4A2 gene directly implied as the cause of Parkinson’s or Alzheimer’s disease, there is strong evidence for the importance of a putative pharmacological modulation of this gene to revert or ameliorate the symptoms in these highly prevalent diseases.